Michael R. Bristow, President & Chief Executive Offic at ARCA biopharma, Inc. (ABIO), sold 1,972 shares at $2.89 ($6K) on 2016-09-20, disclosed to the SEC on 2016-09-21.
Scheduled sale ($6k) by President & Chief Executive Offic under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABIO | SELL | 2016-04-06 | $3K | — | Filing → |
| ABIO | SELL | 2016-03-02 | $3K | — | Filing → |
| ABIO | SELL | 2015-09-21 | $11K | — | Filing → |